Full text is available at the source.
Abstract
Obesity is a global health burden with increasing prevalence.
- Semaglutide is being investigated as a part of combination therapies for obesity treatment.
- Combination regimens may enhance the effectiveness of anti-obesity treatments.
- Research into pairing semaglutide with other agents is a growing area of interest.
Simplified